TGF-βs and TGF-β receptors in atherosclerosis

National Center for Health Statistics. Deaths: Final Data for 1997. Vol. 47, No. 19. 108, 1999. pp. (PHS) 99–1120 Atherosclerosis of the aorta and coronary arteries in five towns. Bulletin of the World Health Organization 1976;53(5–6):485–645 Herrman, 1993, Pharmacological approaches to the prevention of restenosis following angioplasty: The search for the Holy Grail? (Part I), Drugs, 46, 18, 10.2165/00003495-199346010-00003 Volteas, 1994, Risk factor associated with recurrent carotid stenosis, IntAngiol., 13, 143 Leimgruber, 1986, Restenosis after successful coronary angioplasty in patients with single-vessel disease, Circulation, 73, 710, 10.1161/01.CIR.73.4.710 Serruys, 1995, A comparison of hirudin with heparin in the prevention of retenosis after coronary angioplasty. Helvetica Investigators, N. Engl. J. Med., 333, 757, 10.1056/NEJM199509213331203 The, 1999, Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study), Circulation, 100, 799, 10.1161/01.CIR.100.8.799 Bochaton-Piallat, 1995, Apoptosis participates in cellularity regulation during rat aortic intimal thickening, Am. J. Pathol., 146, 1059 Stemerman, 1982, Vascular smooth muscle cell growth kinetics in vivo in aged rats, Proc. Natl. Acad. Sci. USA, 79, 3863, 10.1073/pnas.79.12.3863 Hariri, 1986, Aging and atherosclerosis I. Development of myointimal hyperplasia after endothelial injury, J. Exp. Med., 164, 1171, 10.1084/jem.164.4.1171 Hariri, 1988, Aging and atherosclerosis. Cell cycle kinetics of young and old arterial smooth muscle cells, Am. J. Pathol., 131, 132 Mehta, 1995, Spontaneous regression of restenosis: an angiographic study, J. Am. Coll. Cardiol., 26, 696, 10.1016/0735-1097(95)00335-2 Rembold, 1996, Could atherosclerosis originate from defective smooth muscle cell death?, Persp. Biol. Med., 39, 405, 10.1353/pbm.1996.0000 Lyons, 1990, Mechanism of activation of latent recombinant transforming growth factor-β1 by plasmin, J. Cell Biol., 110, 1361, 10.1083/jcb.110.4.1361 Lawrence, 1984, Normal embryo fibroblasts release transforming growth factors in a latent form, J. Cell Physiol., 121, 184, 10.1002/jcp.1041210123 Lyons, 1988, Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium, J. Cell Biol., 106, 1659, 10.1083/jcb.106.5.1659 Kojima, 1993, Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells, J. Cell Biol., 121, 439, 10.1083/jcb.121.2.439 Schultz-Cherry, 1994, The Type 1 repeats of thrombospondin 1 activate latent transforming growth factor-β, J. Biol. Chem., 269, 26783, 10.1016/S0021-9258(18)47087-1 Mooradian, 1989, Transforming growth factor-β1 binds to immobilized fibronectin, J. Cell Biochem., 41, 189, 10.1002/jcb.240410404 Murphy-Ullrich, 1992, Transforming growth factor-β complexes with thrombospondin, Mol. Biol. Cell, 3, 181, 10.1091/mbc.3.2.181 Paralkar, 1991, Transforming growth factor-β type 1 binds to collagen IV of basement membrane matrix: Implications for development, Dev. Biol., 143, 303, 10.1016/0012-1606(91)90081-D Flanders, 1989, Transforming growth factor-β1: Histochemical localization with antibodies to different epitopes, J. Cell Biol., 108, 653, 10.1083/jcb.108.2.653 Falcone, 1993, Macrophage and foam cell release of matrix bound growth factors: role of plasminogen activation, J. Biol. Chem., 268, 11951, 10.1016/S0021-9258(19)50292-7 McCaffrey, 1992, Transforming growth factor-β is a heparin-binding protein: Identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-β1, J. Cell Physiol., 152, 430, 10.1002/jcp.1041520226 McCaffrey, 1989, Transforming growth factor-β activity is potentiated by heparin via dissociation of the transforming growth-β/∗2-macroglobulin inactive complex, J. Cell Biol., 109, 441, 10.1083/jcb.109.1.441 Grainger, 1993, Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor β-like activity from serum, Cardiovasc. Res., 27, 2238 Nikol, 1992, Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions, J. Clin. Invest., 90, 1582, 10.1172/JCI116027 Majesky, 1991, Production of transforming growth factor-β1 during repair of arterial injury, J. Clin. Invest., 88, 904, 10.1172/JCI115393 Wolf, 1994, Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model, J. Clin. Invest., 93, 1172, 10.1172/JCI117070 Saltis, 1996, Regulation and interactions of transforming growth factor-beta with cardiovascular cells: implications for development and disease, Clin. Exp. Pharmacol. Physiol., 23, 193, 10.1111/j.1440-1681.1996.tb02595.x Heimark, 1986, Inhibition of endothelial regeneration by type-β transforming growth factor from platelets, Science, 233, 1078, 10.1126/science.3461562 Bell, 1989, Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells, Circ. Res., 65, 1057, 10.1161/01.RES.65.4.1057 Chen, 1987, Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells, Proc. Natl. Acad. Sci. USA, 84, 5287, 10.1073/pnas.84.15.5287 Madri, 1989, Endothelial cell behavior after denudation injury is modulated by transforming growth factor-β1 and fibronectin, Lab. Invest., 60, 755 Pepper, 1993, Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis, Exp. Cell Res., 204, 356, 10.1006/excr.1993.1043 Assoian, 1986, Type β transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells, J. Cell Biol., 102, 1217, 10.1083/jcb.102.4.1217 Bjorkerud, 1991, Effects of transforming growth factor-β1 on human arterial smooth muscle cells in vitro, Arteriosclerosis, 11, 892, 10.1161/01.ATV.11.4.892 Battegay, 1990, TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop, Cell, 63, 515, 10.1016/0092-8674(90)90448-N Topouzis, 1996, Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta, Dev. Biol., 178, 430, 10.1006/dbio.1996.0229 Pollman, 1999, Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-β1 in endothelial cells versus smooth muscle cells, Circulation, 99, 2019, 10.1161/01.CIR.99.15.2019 Bennett, 1997, Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis, Circ. Res., 81, 591, 10.1161/01.RES.81.4.591 McCaffrey, 1999, The expression of TGF-β receptors in human atherosclerosis: evidence for acquired resistance due to receptor imbalance, J. Mol. Cell Cardiol., 31, 1627, 10.1006/jmcc.1999.0999 Tsunawaki, 1988, Deactivation of macrophages by transforming growth factor-beta, Nature, 334, 260, 10.1038/334260a0 Falcone, 1993, Transforming growth factor-β1 stimulates macrophage urokinase expression and release of matrix bound basic fibroblast growth factor, J. Cell Physiol., 155, 595, 10.1002/jcp.1041550317 Ross, 1990, Localization of PDGF-B protein in macrophages in all stages of atherogenesis, Science, 248, 1009, 10.1126/science.2343305 Lomo, 1995, TGF-β1 and cyclic AMP promote apoptosis in resting human B lymphocytes, J. Immunol., 154, 1634, 10.4049/jimmunol.154.4.1634 Nabel, 1993, Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia, Proc. Natl. Acad. Sci. USA, 90, 10759, 10.1073/pnas.90.22.10759 Kanzaki, 1995, In vivo effect of TGF-β1: enhanced intimal thickening by administration of TGF-β1 in rabbit arteries injured with a balloon catheter, Arterioscler. Thromb., 15, 1951, 10.1161/01.ATV.15.11.1951 Grainger, 1994, Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice, Nature, 370, 460, 10.1038/370460a0 Sarzani, 1989, Growth factor expression in aorta of normotensive and hypertensive rats, J. Clin. Invest., 83, 1404, 10.1172/JCI114029 Bobik, 1999, Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development, Circulation, 99, 2883, 10.1161/01.CIR.99.22.2883 McCaffrey, 1988, Aging and Arteriosclerosis: The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity, J. Exp. Med., 167, 163, 10.1084/jem.167.1.163 Bochaton-Piallat, 1993, Age influences the replicative activity and the differentiation features of cultured rat aortic smooth muscle cell populations and clones, Arterioscler. Thromb., 13, 1449, 10.1161/01.ATV.13.10.1449 McCaffrey, 1993, Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-β in vascular smooth muscle cells, Mol. Biol. Cell, 4, 315, 10.1091/mbc.4.3.315 Saltis, 1994, Developmentally regulated transforming growth factor-beta 1 action on vascular smooth muscle growth in the SHR, Clin. Exp. Pharmacol. Physiol., 21, 149, 10.1111/j.1440-1681.1994.tb02485.x Narhi, 1993, Conformation of glutathione adduct and oxidized forms of platelet-derived growth factor, Int. J. Pept. Protein Res., 41, 8, 10.1111/j.1399-3011.1993.tb00109.x McCaffrey, 1995, Decreased Type II/Type I TGF-β1 receptor ratio in cells derived from human atherosclerotic lesions: conversion from an antiproliferative to profibrotic response to TGF-β1, J. Clin. Invest., 96, 2667, 10.1172/JCI118333 Grotendorst, 1997, Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts, Cytokine Growth Factor Rev., 8, 171, 10.1016/S1359-6101(97)00010-5 Chen, 1993, Inactivation of the Type II receptor reveals two receptor pathways for the diverse TGF-β activities, Science, 260, 1335, 10.1126/science.8388126 Markowitz, 1995, Inactivation of the Type II TGF-β receptor in colon cancer cells with microsatellite instability, Science, 268, 1336, 10.1126/science.7761852 McCaffrey, 1997, Genomic instability in the Type II TGF-β1 receptor gene in atherosclerotic and restenotic vascular cells, J. Clin. Invest., 100, 2182, 10.1172/JCI119754 Choi, 1998, A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptor, J. Biol. Chem., 273, 110, 10.1074/jbc.273.1.110 Humphries, 1994, Structure and expression of the promoter for the human type II transforming growth factor-Beta receptor, Biochem. Biophys. Res. Commun., 203, 1020, 10.1006/bbrc.1994.2284 Bae, 1995, Characterization of the promoter region of the human transforming growth factor-β Type II receptor gene, J. Biol. Chem., 270, 29460, 10.1074/jbc.270.49.29460 Ammanamanchi, 1998, Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2′-deoxycytidine, J. Biol. Chem., 273, 16527, 10.1074/jbc.273.26.16527 Bray, 1999, Glucocorticoid resistance due to reduced expression of the glucocorticoid receptor and heat shock protein 90 in cells from human vascular lesions, Arterioscler. Thromb. Vasc. Biol., 19, 1180, 10.1161/01.ATV.19.5.1180